The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase III trial comparing long-term versus short-term androgen deprivation combined with high-dose radiotherapy for localized prostate cancer: GICOR protocol DART01/05.
A. Zapatero
No relevant relationships to disclose
A. Guerrero
No relevant relationships to disclose
X. Maldonado
No relevant relationships to disclose
A. Alvarez
No relevant relationships to disclose
C. González San Segundo
No relevant relationships to disclose
A. Cabeza
No relevant relationships to disclose
V. Macías
No relevant relationships to disclose
F. Casas
No relevant relationships to disclose
A. Pedro-Olivé
No relevant relationships to disclose
S. Villa
No relevant relationships to disclose
A. Boladeras
No relevant relationships to disclose
M. L. Vazquez de La Torre
No relevant relationships to disclose
C. Martin de Vidales
No relevant relationships to disclose
F. A. Calvo
No relevant relationships to disclose